Insights

Deep 6 AI Acquired by Tempus

Download Now

Deal Insights

IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates

Learn More

Deal Insights

Deep 6 AI Acquired by Tempus

Learn More

/ 6

Type

Article

Bluebook

Case Study

Deal Insight

Market Map

Video

Whitepaper

Industry

Precision Medicine

Pharma Services

Diagnostics and Tools

Digital Health

Bluebook

Pharma Services: Drug Development BlueBook March 2025

Highlights from this edition: Clinilabs was acquired by InTandem Capital Partners, Kardigan announced its acquisition of Prolaio, Mendel Health ...

Download Now

Bluebook

Pharma Services: Drug Supply Chain BlueBook March 2025

Highlights from this edition: Gateway Medical Pharmacy was acquired by Medicure Pharma, RedSail Technologies announced its acquisition of Emporos ...

Download Now

Bluebook

Pharma Services: Pharmaceutical Commerce BlueBook March 2025

Highlights from this edition: Mercalis was acquired by PharmaCord, TIS International announced its acquisition of Glidian, Silna Health closed a ...

Download Now

Bluebook

Pharma Services: Pharma Technology BlueBook March 2025

Highlights from this edition: Deep 6 AI was acquired by Tempus AI, PharmaCord announced its acquisition of Mercalis, Experiad closed a $27MM Series A ...

Download Now

Deal Insights

IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates

Learn More

Learn More

Deal Insights

Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network

Learn More

Bluebook

Pharma Services: Drug Development June 2024

Highlights from this edition: Pro-Ficiency Holdings was acquired by Simulations Plus, Inc. (NasdaqGS:SLP), Integral Diagnostics Limited (ASX:IDX) ...

Download Now

Bluebook

Diagnostics and Tools June 2024

Highlights from this edition: Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners, RareCyte closed a $20MM Growth Financing, ...

Download Now

Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US

Learn More

Deal Insights

Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

Learn More

Bluebook

Diagnostics and Tools March 2024

Highlights from this edition: Invicro, LLC was acquired by Calyx Services Inc., Telix Pharmaceuticals Limited (ASX:TLX) announced its acquisition of ...

Download Now

Bluebook

Pharma Services: Drug Development March 2024

Highlights from this edition: Endpoint Clinical and Patient Access Businesses of Fortrea was acquired by Arsenal Capital Partners, Calyx Services ...

Download Now

Deal Insights

physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

Learn More

Bluebook

Diagnostics and Tools February 2024

Highlights from this edition: Freenome, Inc. closed a $254MM Series A Financing, led by Roche Diagnostics Corporation, Triple Ring Technologies ...

Download Now

Bluebook

Pharma Services: Drug Development February 2024

Highlights from this edition: Continuum Clinical was acquired by Spectrum Science a Portfolio Company of Knox Lane, Headlands Research announced its ...

Download Now

Deal Insights

Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities

Learn More

Deal Insights

Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally

Learn More

Bluebook

Pharma Services: Drug Development January 2024

Highlights from this edition: Science 37 Holdings, Inc. was acquired by eMed, LLC, Janvier Labs announced its acquisition of Yecuris, Neocis, In. ...

Download Now

Bluebook

Diagnostics and Tools January 2024

Highlights from this edition: Sofie Biosciences, Inc. (25.8% stake) was acquired by Trilantic Capital Management L.P., Roche Diagnostics Corporation ...

Download Now

Deal Insights

Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering

Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room ...

Learn More

Diagnostics and Tools August 2023

Highlights from this edition: QDx Pathology was acquired by LabGenomics Experity, Inc. announced its acquisition of OnePacs, LLC Viome, Inc....

Download Now

Deal Insights

Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform

Learn More

Deal Insights

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand ...

Learn More

Deal Insights

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

Learn More

Bluebook

Pharma Services July 2023

Highlights from this edition: Genpro Research Inc. was acquired by Catalyst Clinical Research, LLC Alcanza Clinical Research, LLC announced its...

Download Now

Bluebook

Diagnostics and Tools July 2023

Highlights from this edition: Quantigen, LLC was acquired by Versiti, Inc. Novacyt UK Holdings Limited announced its acquisition of Yourgene...

Download Now

Deal Insights

Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings

Catalyst Clinical Research, a portfolio company of QHP Capital, acquired Genpro Research to expand global footprint and deepen service offerings

Learn More

Deal Insights

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network ...

Learn More

OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials

The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.

Learn More

Deal Insights

Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities

Boca’s high growth profile and differentiated positioning within the biobanking industry made it the ideal acquisition for Clairvest’s ongoing ...

Learn More

Bluebook

Pharma Services February 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now

Bluebook

Diagnostics and Tools February 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now

Deal Insights

RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions

Learn More

Quartesian Acquired by Summit Partners to Form New Global Outsourced Medtech Provider

Global independent biometrics company, Quartesian, acquired by Summit Partners to form key pillar of newly established global outsourced medtech ...

Learn More

PharmaVOICE: February 2021

Fueled by the strong financial performance of Pharma Services, Diagnostics and Tools, and Digital Health companies and accelerated by the COVID-19 ...

Learn More

Deal Insights

Trifecta Clinical was acquired by WCG

Overview WCG has acquired Los Angeles-based Trifecta Clinical to bolster its remote study startup and compliance support offerings. Significance WCG ...

Learn More

Bluebook

Diagnostics & Tools November 2020

Talis Biomedical Corporation received a $126mm round of funding Change Healthcare sold assets to HealthStream Congenica closed a $51.2mm round...

Download Now

Bluebook

Pharma Services November 2020

IntegReview IRB was acquired by Advarra Shanghai Youlin Pharmaceutical Technology closed a $14.9mm round of funding, led by Cenova Ventures...

Download Now

Deal Insights

IntegReview was acquired by Advarra

Download Now

Bluebook

Diagnostics & Tools August 2020

Ancestory.com was acquired by The Blackstone Group Varian Medical Systems was acquired by Siemens Healthineers Coastal Genomics was acquired by...

Download Now

Deal Insights

GSK is selling assets to Foundation Consumer Healthcare

Overview Foundation Consumer Healthcare owned by Kelso Private Equity and Juggernaut Capital, has entered into an agreement to acquire seven branded ...

Overview On November 14, 2019, Leonard Green & Partners, L.P. (“LGP”), in partnership with Arsenal Capital Partners (“Arsenal”) and Novo Holdings ...

Overview On September 4, 2019, Perrigo acquired branded rights to Prevacid® from GlaxoSmithKline. Under the terms of the agreement, Perrigo will have ...

Crosstree Capital Partners acted as exclusive financial advisor to Citoxlab.

Learn More

Deal Insights

SunLink Sold Assets to CVS Health

GSK sold assets to Lilâ€™ Drug Store

Deal Insights

ProPhase acquired by WCG and Arsenal Capital Partners May 9, 2017

Overview WIRB-Copernicus Group (WCGTM) announced its acquisition of MedAvante and ProPhase. WCG is the leading provider of solutions that improve the ...

Learn More